Alan M. Krensky, M.D.
Publications
- 15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level. J Transl Med. 2011: 41
- Expression and purification of 15 kDa granulysin utilizing an insect cell secretion system. Protein Expr Purif. 2011; (1): 70-4
- Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells. J Immunol. 2011; (6): 3497-504
- Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth. Clin Dev Immunol. 2011: 438463
- KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells. J Exp Med. 2011; (5): 1093-103
- Monocyte-derived DC maturation strategies and related pathways: a transcriptional view. Cancer Immunol Immunother. 2011; (4): 457-66
- Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood. 2010; (18): 3465-74
- Granulysin production and anticryptococcal activity is dependent upon a far upstream enhancer that binds STAT5 in human peripheral blood CD4+ T cells. J Immunol. 2010; (9): 5074-81
- National Institutes of Health Center for Human Immunology Conference, September 2009. Ann N Y Acad Sci. 2010: E1-23
- Ten years of the Immune Tolerance Network: an integrated clinical research organization. Sci Transl Med. 2010; (19): 19cm7
- A human T cell-specific molecule is a member of a new gene family. 1988. J Immunol. 2009; (7): 3947-54
- Biology and clinical relevance of granulysin. Tissue Antigens. 2009; (3): 193-8
- Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol. 2008 Jan-Mar; (1): 117-27
- IL-24 modulates IFN-gamma expression in patients with tuberculosis. Immunol Lett. 2008; (1): 57-62
- IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin Immunol. 2008; (2): 202-10
- In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae. J Antimicrob Chemother. 2008; (5): 1103-9
- Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients. J Immunol. 2008; (11): 7221-9
- XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma. J Immunol. 2008; (8): 5386-95
- Forest bathing enhances human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol. 2007 Apr-Jun; (2 Suppl 2): 3-8
- Alan Krensky interview. Drawing a map for the twenty-seven divisions in NIH's army. Science. 2007; (5840): 887
- Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids. J Allergy Clin Immunol. 2007; (6): 1441-8
- Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins. Biochim Biophys Acta. 2007; (10): 2421-31
- CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc Natl Acad Sci U S A. 2007; (26): 11008-13
- Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients. Blood. 2007; (5): 2049-57
- Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb). 2007; (4): 322-8
- Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes. Mol Cell Biol. 2007; (1): 253-66
- Granulysin-mediated tumor rejection in transgenic mice. J Immunol. 2007; (1): 77-84
- Healthy lifestyles are associated with higher levels of perforin, granulysin and granzymes A/B-expressing cells in peripheral blood lymphocytes. Prev Med. 2007; (2): 117-23
- Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription. J Immunol. 2007; (11): 7081-7
- Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo. J Immunol. 2007; (9): 5496-504
- Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol. 2007; (3): 164-70
- Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J Immunol. 2007; (6): 3688-94
- Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin. Infect Immun. 2007; (7): 3658-64
- Cell selectivity correlates with membrane-specific interactions: a case study on the antimicrobial peptide G15 derived from granulysin. Biochim Biophys Acta. 2006; (2): 154-63
- Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J Immunol. 2006; (5): 2770-4
- Phytoncides (wood essential oils) induce human natural killer cell activity. Immunopharmacol Immunotoxicol. 2006; (2): 319-33
- A novel apoptosis pathway activated by the carboxyl terminus of p21. Blood. 2005; (3): 1187-94
- Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. J Immunol. 2005; (11): 7474-83
- Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly decreases the expression of perforin, granzyme A and granulysin in human NK-92CI cell line. Toxicology. 2005; (1-2): 107-16
- Glycosylated recombinant human XCL1/lymphotactin exhibits enhanced biologic activity. J Immunol Methods. 2005; (1-2): 136-44
- Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol. 2005; (9): 5243-8
- Granulysin: a novel host defense molecule. Am J Transplant. 2005; (8): 1789-92
- Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Antimicrob Agents Chemother. 2005; (1): 388-97
- Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1. Int J Cancer. 2005; (5): 747-55
- Elevated expression of CCL5/RANTES in adult T-cell leukemia cells: possible transactivation of the CCL5 gene by human T-cell leukemia virus type I tax. Int J Cancer. 2004; (4): 548-57
- Gamma delta T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur J Immunol. 2004; (8): 2248-56
- Lesional T cells and dermal dendrocytes in psoriasis plaque express increased levels of granulysin. J Am Acad Dermatol. 2004; (6): 1006-8
- NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol. 2004; (5): 3357-65
- CD40 ligand trimer enhances the response of CD8+ T cells to Mycobacterium tuberculosis. J Immunol. 2003; (6): 3180-6
- DQ 65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation. J Immunol. 2003; (10): 5064-70
- Granulysin crystal structure and a structure-derived lytic mechanism. J Mol Biol. 2003; (2): 355-65
- Granulysin. Curr Opin Immunol. 2003; (5): 560-5
- Helicobacter pylori induces RANTES through activation of NF-kappa B. Infect Immun. 2003; (7): 3748-56
- Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol. 2003; (6): 3154-61
- Intracellular mediators of granulysin-induced cell death. J Immunol. 2003; (5): 2556-62
- Society for Pediatric Research Presidential Address 2002: first principles. Pediatr Res. 2003; (3): 513-5
- A T cell-specific enhancer of the human CD40 ligand gene. J Biol Chem. 2002; (9): 7386-95
- A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest. 2002; (1): 119-26
- CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. J Immunol. 2002; (10): 5787-95
- DQ 65-79, a peptide derived from HLA class II, induces I kappa B expression. J Immunol. 2002; (7): 3323-8
- Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like transcription factor of activated T lymphocytes. J Biol Chem. 2002; (33): 30055-65
- Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes. J Infect Dis. 2002; (7): 991-8
- Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis. J Infect Dis. 2002; (12): 1835-9
- A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol. 2001; (1): 350-6
- A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem. 2001; (6): 4199-204
- A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J Immunol. 2001; (3): 1222-9
- Chemokines and allograft rejection: narrowing the list of suspects. Transplantation. 2001; (7): 1195-7
- Chemokines, chemokine receptors, and allograft rejection. Immunity. 2001; (4): 377-86
- Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells. Viral Immunol. 2001; (2): 125-33
- Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol. 2001; (1): 21-31
- Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis. 2001; (8): 1082-5
- Granulysin: a novel antimicrobial. Expert Opin Investig Drugs. 2001; (2): 321-9
- Immunologic tolerance. Pediatr Nephrol. 2001; (8): 675-9
- T-cell release of granulysin contributes to host defense in leprosy. Nat Med. 2001; (2): 174-9
- A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling. J Clin Invest. 2000; (10): 1447-53
- An immunosuppressive and anti-inflammatory HLA class I-derived peptide binds vascular cell adhesion molecule-1. Transplantation. 2000; (4): 662-7
- Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J Immunol. 2000; (3): 1486-90
- Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol. 2000; (12): 7102-8
- Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem Pharmacol. 2000; (4): 317-20
- Interleukin-1beta induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors. J Neuroimmunol. 2000; (1): 78-90
- Molecular biology of transplantation. Nephron. 2000; (3): 260-5
- Proliferating cell nuclear antigen as the cell cycle sensor for an HLA-derived peptide blocking T cell proliferation. J Immunol. 2000; (12): 6188-92
- Role of granulysin in immunity to leprosy. Lepr Rev. 2000: S115; discussion S115-6
- Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med. 2000; (6): 937-48
- The immune tolerance network: the "Holy Grail" comes to the clinic. J Am Soc Nephrol. 2000; (11): 2141-6
- Transcriptional regulation of RANTES expression in T lymphocytes. Immunol Rev. 2000: 236-45
- Biosynthesis of granulysin, a novel cytolytic molecule. Mol Immunol. 1999; (7): 413-22
- Granulysin: a lethal weapon of cytolytic T cells. Immunol Today. 1999; (9): 390-4
- HLA-derived peptides as novel immunomodulatory therapeutics. J Am Soc Nephrol. 1999; (6): 1346-55
- RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity. 1999; (1): 93-103
- The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of Nephrology. J Am Soc Nephrol. 1999; (10): 2237-43
- An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 1998; (5386): 121-5
- Chemokines, lymphocytes and viruses: what goes around, comes around. Curr Opin Immunol. 1998; (3): 265-70
- Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol. 1998; (4): 1758-64
- Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin. J Immunol. 1998; (5): 2215-22
- Pediatric Transplant Grand Rounds. Pediatric kidney transplantation at Stanford. Pediatr Transplant. 1998; (2): 165-76
- Expression of chemokine RANTES and production of monoclonal antibodies. Methods Enzymol. 1997: 162-74
- Gene expression of RANTES. Methods Enzymol. 1997: 148-62
- Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol. 1997; (2): 117-25
- HLA-derived peptides as novel immunosuppressives. Nephrol Dial Transplant. 1997; (5): 865-8
- New insights into mechanisms of allograft rejection. Am J Med Sci. 1997; (5): 257-63
- Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol. 1997; (6): 2680-8
- SCID mouse models: more than furry flasks. Nat Biotechnol. 1997; (8): 720-1
- Switching gears during T-cell maturation: RANTES and late transcription. Immunol Today. 1997; (10): 468-71
- The HLA system, antigen processing and presentation. Kidney Int Suppl. 1997: S2-7
- Cytotoxic T lymphocyte recognition of non-Hodgkin's B cell lymphomas. Immunol Res. 1996; (2): 91-7
- HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family. J Exp Med. 1996; (2): 339-48
- Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J Immunol. 1996; (3): 1139-48
- Immunologic tolerance: tailored antigen. Transplant Proc. 1996; (4): 2075-7
- Immunomodulation by HLA class I-derived peptides. Transplant Proc. 1996; (6): 3026-8
- Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol. 1996; (1): 202-10
- Novel immunotherapeutic strategies using MHC derived peptides. Kidney Int Suppl. 1996: S13-20
- RANTES chemokine expression in diseased and normal human tissues. Cytokine. 1996; (1): 89-98
- RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant. 1996; (12): 1194-9
- Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol. 1996; (1): 160-7
- Structure of HLA molecules and immunosuppressive effects of HLA derived peptides. Int Rev Immunol. 1996; (3): 173-85
- Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood. 1996; (2): 580-9
- Gamma delta T cell recognition of tumor Ig peptide. J Immunol. 1995; (4): 1614-23
- HLA-derived peptides as novel immunosuppressives. Pediatr Res. 1995; (3): 275-9
- HLA-derived peptides as novel immunotherapeutics. Clin Immunol Immunopathol. 1995; (2): 112-6
- Human leukocyte antigen-derived peptides as novel immunosuppressives. Proc Assoc Am Physicians. 1995; (1): 81-5
- Immunosuppressive peptides corresponding to MHC class I sequences. Curr Opin Immunol. 1995; (5): 644-8
- Novel tumor-associated accessory molecules involved in the gamma/delta cytotoxic T-lymphocyte-Burkitt's lymphoma interaction. Cancer. 1995; (3): 886-93
- Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J Immunol. 1994; (8): 3786-92
- Peptides corresponding to the CD8 and CD4 binding domains of HLA molecules block T lymphocyte immune responses in vitro. J Immunol. 1994; (3): 946-51
- Prospects for induction of tolerance in renal transplantation. Pediatr Nephrol. 1994; (6): 772-9
- RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet. 1994; (8891): 209-11
- T cells in autoimmunity and allograft rejection. Kidney Int Suppl. 1994: S50-6
- The induction of tolerance to alloantigens using HLA-based synthetic peptides. Curr Opin Immunol. 1994; (5): 791-6
- Transplantation immunology. Pediatr Clin North Am. 1994; (4): 819-39
- Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol. 1993; (5): 2601-12
- Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure. Pediatr Nephrol. 1993; (4): 416-23
- Monocyte haptotaxis induced by the RANTES chemokine. Curr Biol. 1993; (11): 735-9
- Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses. Transplant Proc. 1993; (1 Pt 1): 477-8
- Peptides corresponding to the CD8 binding region of HLA class I block the differentiation of cytotoxic T lymphocyte precursors. Transplant Proc. 1993; (1 Pt 1): 483-4
- TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int. 1993; (4): 795-804
- The CD8 coreceptor interaction with the alpha 3 domain of HLA class I is critical to the differentiation of human cytotoxic T-lymphocytes specific for HLA-A2 and HLA-Cw4. Hum Immunol. 1993; (3): 149-55
- The nature of allorecognition. Curr Opin Nephrol Hypertens. 1993; (6): 898-903
- Effect of the substitution of critical residues on the allorecognition of HLA-B27. Clin Exp Rheumatol. 1992 Nov-Dec; (6): 583-7
- Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27. J Exp Med. 1992; (3): 809-20
- Genomic structure and alternative splicing of 519, a gene expressed late after T cell activation. J Immunol. 1992; (12): 4036-42
- Human cytotoxic T-lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion. Cancer. 1992; (8): 2181-6
- Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. J Immunol. 1992; (8): 2600-8
- Interleukin 3 is a growth factor for human follicular B cell lymphoma. J Exp Med. 1992; (2): 371-6
- Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. Kidney Int. 1992; (1): 220-5
- Generation of monoclonal antibodies against soluble human T cell receptor polypeptides. Eur J Immunol. 1991; (9): 2111-9
- Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells. Kidney Int. 1991; (2): 312-9
- Molecular basis of transplant rejection and acceptance. Pediatr Nephrol. 1991; (4): 422-7
- A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature. 1990; (6270): 41-6
- Continuous venovenous hemofiltration. Pediatr Nephrol. 1990; (6): 640-2
- Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12. Genomics. 1990; (3): 548-53
- Localization of the human T lymphocyte activation gene 519 (D2S69E) to chromosome 2p12----q11. Cytogenet Cell Genet. 1990; (4): 230-1
- Molecular cloning and characterization of WP34, a phosphorylated human lymphocyte differentiation and activation antigen. Eur J Immunol. 1990; (11): 2417-23
- Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes. J Immunol. 1990; (11): 4172-6
- T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med. 1990; (8): 510-7
- The importance of the ICAM-1/LFA-1-dependent pathway in in vitro cytotoxicity against cultured human kidney cells. Transplant Proc. 1990; (5): 2101-2
- Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol. 1990; (4): 303-7
- A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes. J Immunol. 1989; (6): 2097-104
- Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain. J Exp Med. 1989; (5): 1557-64
- Diversity of class I HLA molecules: functional and evolutionary interactions with T cells. Cold Spring Harb Symp Quant Biol. 1989: 529-43
- Expression of LFA-1 in non-Hodgkin's lymphoma. Cancer. 1989; (2): 255-9
- Histamine regulates the generation of human cytolytic T lymphocytes. Cell Immunol. 1989; (1): 60-73
- Microvascular destruction in renal transplant rejection. Transplantation. 1989; (3): 408-14
- Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature. 1989; (6213): 345-7
- The molecular basis of renal transplant rejection. Semin Nephrol. 1989; (1): 116-9
- A human T cell-specific molecule is a member of a new gene family. J Immunol. 1988; (3): 1018-25
- Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule. J Immunol. 1988; (11): 4005-11
- Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3. J Immunol. 1988; (7): 2519-25
- Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes and a Leu-3+ T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA-1 molecule. J Invest Dermatol. 1988; (1): 17-22
- Rescue of Daudi cell HLA expression by transfection of the mouse beta 2-microglobulin gene. J Exp Med. 1988; (2): 288-99
- Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature. 1987 Feb 12-18; (6105): 625-8
- HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature. 1987 Dec 24-31; (6150): 763-5
- Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet. 1987; (8558): 533-6
- Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines. J Immunol. 1987; (7): 2019-23
- Human allospecific cytolytic T lymphocyte lysis of a murine cell transfected with HLA-A2. J Immunol. 1987; (7): 2044-9
- Identification and characterization of two novel lymphocyte function-associated antigens, L24 and L25. J Immunol. 1987; (5): 1510-4
- In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. J Exp Med. 1987; (1): 283-8
- Rhabdomyolysis complicating doxylamine overdose. Clin Pediatr (Phila). 1987; (11): 595-7
- The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med. 1987; (3): 601-14
- Function and cell distribution of KC-1, a novel natural killer cell-associated antigen. J Immunol. 1986; (5): 1537-41
- Mapping functional epitopes of the human LFA-1 glycoprotein: monoclonal antibody inhibition of NK and CTL effectors. Hum Immunol. 1986; (3): 288-96
- The modulation of generation/function of human cytotoxic lymphocytes by autacoids: unusually compartmentalized cAMP? Proc West Pharmacol Soc. 1986: 31-4
- Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature. 1985 Feb 21-27; (6004): 686-7
- Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule. J Exp Med. 1985; (5): 1709-14
- Diagnostic and therapeutic implications of T cell surface antigens. Transplantation. 1985; (4): 339-48
- Functional distinctions between the LFA-1, LFA-2, and LFA-3 membrane proteins on human CTL are revealed with trypsin-pretreated target cells. J Immunol. 1985; (1): 244-9
- Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1. J Immunol. 1985; (5): 3102-8
- Human T cell clones express functional homing receptors required for normal lymphocyte trafficking. J Exp Med. 1985; (3): 1075-80
- LFA-1 membrane molecule in the regulation of homotypic adhesions of human B lymphocytes. J Immunol. 1985; (1): 9-11
- Lymphocyte subsets and surface molecules in man. Clin Immunol Rev. 1985; (1): 95-138
- MHC-unrestricted cytolytic T lymphocytes. Surv Immunol Res. 1985; (4): 297-302
- Target specificity and cell surface structures involved in the human cytolytic T lymphocyte response to endothelial cells. J Immunol. 1985; (1): 12-8
- The function of LFA-1 in cell-mediated killing and adhesion: studies on heritable LFA-1, Mac-1 deficiency and on lymphoid cell self-aggregation. Adv Exp Med Biol. 1985: 311-22
- The human cytolytic T lymphocyte response to transplantation antigens. Pediatr Res. 1985; (12): 1231-4
- A molecular analysis of the cytolytic T lymphocyte response. Adv Immunol. 1984: 45-85
- Experimental evidence for the potential usefulness of permanent IL-3-dependent multipotential hematopoietic progenitor cell lines in transfusion granulocyte support therapy: need for expansion of early passage cells. Kroc Found Ser. 1984: 255-69
- Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol. 1984; (6): 3011-8
- Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. J Immunol. 1984; (4): 1878-84
- Human lymphocyte function-associated antigens. Surv Immunol Res. 1984; (1): 39-44
- Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens. Immunobiology. 1984; (3-5): 483-94
- LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation. J Immunol. 1984; (5): 2180-2
- Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes. Exp Hematol. 1984; (9): 720-7
- Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature. 1983 Oct 20-26; (5936): 726-9
- A DC-specific cytolytic T lymphocyte line is OKT8+1. J Immunol. 1983; (6): 2777-80
- Basic science seminar: cytotoxic T-lymphocyte response to HLA antigens. J Pediatr. 1983; (6): 814-9
- Causes of increased renal echogenicity in pediatric patients. Pediatrics. 1983; (6): 840-6
- Cytotoxic T cells directed against HLA-DR antigens and their surface proteins. Diagn Immunol. 1983; (3): 116-9
- Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome. Hum Immunol. 1983; (2): 75-7
- Hemolytic uremic syndrome and crescentic glomerulonephritis complicating childhood nephrosis. Clin Nephrol. 1983; (2): 99-106
- Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity. J Immunol. 1983; (3): 1182-8
- The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol. 1983; (2): 611-6
- Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med. 1983; (20): 1192-6
- Generation of long-term human cytolytic cell lines with persistent natural killer activity. J Immunol. 1982; (4): 1748-51
- Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol. 1982; (1): 100-12
- Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A. 1982; (7): 2365-9
- Peritonitis in childhood nephrotic syndrome: 1970-1980. Am J Dis Child. 1982; (8): 732-6
- Specificity of OKT4+ cytotoxic T lymphocyte clones. J Immunol. 1982; (5): 2001-3
- Technique for infrequent arterial blood gas monitoring in the newborn. Clin Pediatr (Phila). 1982; (1): 57
- Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A. 1982; (23): 7489-93
- Elevated nephrogenous cyclic adenosine monophosphate to monitor early renal osteodystrophy. Clin Nephrol. 1981; (5): 245-50
- HLA antigens in mucocutaneous lymph node syndrome in New England. Pediatrics. 1981; (5): 741-3
- Mucocutaneous lymph node syndrome and hydropic gallbladders. Pediatrics. 1980; (5): 814
- Streptococcal antigenicity in mucocutaneous lymph node syndrome and hydropic gallbladders. Pediatrics. 1979; (6): 979-80
- Identification of heterozygote carriers of congenital adrenal hyperplasia by radioimmunoassay of serum 17-OH progesterone. J Pediatr. 1977; (6): 930-3
Help
Trial Administration